All Stories

  1. Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Jonathan L Katz

  2. σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration

    Article • Journal of Pharmacology and Experimental Therapeutics, April 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Jonathan L Katz

  3. Further delineation between typical and atypical dopamine uptake inhibitors

    Article • Behavioural Pharmacology, February 2017, Wolters Kluwer Health

    Jonathan L Katz

  4. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice

    Article • European Journal of Neuroscience, September 2016, Wiley

    Dr Gianluigi Tanda, Jonathan L Katz

  5. Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids

    Article • Neuropsychopharmacology, June 2016, Nature

    Dr Gianluigi Tanda, Jonathan L Katz

  6. Blockade of Cocaine or   Receptor Agonist Self Administration by Subtype-Selective   Receptor Antagonists

    Article • Journal of Pharmacology and Experimental Therapeutics, April 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Jonathan L Katz

  7. A role for sigma receptors in stimulant self-administration and addiction

    Article • Behavioural Pharmacology, April 2016, Wolters Kluwer Health

    Jonathan L Katz

  8. 2-Substituted 3 -Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Jonathan L Katz

  9. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction

    Article • January 2016, Springer Science + Business Media

    Jonathan L Katz

  10. Contributions to drug abuse research of Steven R. Goldberg’s behavioral analysis of stimulus-stimulus contingencies

    Article • Psychopharmacology, November 2015, Springer Science + Business Media

    Jonathan L Katz

  11. Dopamine D2-Like Receptors and Behavioral Economics of Food Reinforcement

    Article • Neuropsychopharmacology, July 2015, Nature

    Jonathan L Katz

  12. Erratum to: Behavioral economics of food reinforcement and the effects of prefeeding, extinction, and eticlopride in dopamine D2 receptor mutant mice

    Article • Psychopharmacology, March 2015, Springer Science + Business Media

    Jonathan L Katz

  13. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter

    Article • Drug and Alcohol Dependence, February 2015, Elsevier

    Jonathan L Katz

  14. Choice for response alternatives differing in reinforcement frequency in dopamine D2 receptor mutant and Swiss-Webster mice

    Article • Psychopharmacology, February 2014, Springer Science + Business Media

    Jonathan L Katz

  15. Peter B Dews

    Article • Neuropsychopharmacology, December 2013, Nature

    Jonathan L Katz

  16. Combating Drug Abuse by Targeting Toll-Like Receptor 4 (TLR4)

    Article • October 2013, Defense Technical Information Center (DTIC)

    Jonathan L Katz

  17. Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats

    Article • Psychopharmacology, August 2013, Springer Science + Business Media

    Jonathan L Katz

  18. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice

    Article • Addiction Biology, August 2013, Wiley

    Dr Gianluigi Tanda, Jonathan L Katz

  19. Obituary: Peter B. Dews (1922–2012)

    Article • Psychopharmacology, March 2013, Springer Science + Business Media

    Jonathan L Katz

  20. An influence of delayed reinforcement on the effectiveness of psychostimulants to enhance indices of attention under a five-choice serial reaction time procedure in male rats.

    Article • Experimental and Clinical Psychopharmacology, January 2013, American Psychological Association (APA)

    Jonathan L Katz

  21. Interactions of cocaine with dopamine D2-like antagonists in squirrel monkeys

    Article • Psychopharmacology, November 2012, Springer Science + Business Media

    Jonathan L Katz

  22. Self-Administration of Cocaine Induces Dopamine-Independent Self-Administration of Sigma Agonists

    Article • Neuropsychopharmacology, November 2012, Springer Science + Business Media

    Dr Gianluigi Tanda, Jonathan L Katz

  23. The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration

    Article • Psychopharmacology, September 2012, Springer Science + Business Media

    Jonathan L Katz

  24. R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse

    Article • Biological Psychiatry, September 2012, Elsevier

    Dr Gianluigi Tanda, Jonathan L Katz

  25. Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine

    Article • Drug and Alcohol Dependence, October 2011, Elsevier

    Jonathan L Katz

  26. Lack of cocaine-like discriminative-stimulus effects of σ-receptor agonists in rats

    Article • Behavioural Pharmacology, September 2011, Wolters Kluwer Health

    Dr Gianluigi Tanda, Jonathan L Katz

  27. Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors

    Article • European Journal of Medicinal Chemistry, May 2011, Elsevier

    Jonathan L Katz

  28. Behavioral economics of food reinforcement and the effects of prefeeding, extinction, and eticlopride in dopamine D2 receptor mutant mice

    Article • Psychopharmacology, February 2011, Springer Science + Business Media

    Jonathan L Katz

  29. SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues

    Article • ACS Medicinal Chemistry Letters, January 2011, American Chemical Society (ACS)

    Jonathan L Katz

  30. Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats

    Article • Psychopharmacology, October 2010, Springer Science + Business Media

    Jonathan L Katz

  31. Structure−Activity Relationships for a Novel Series of Citalopram (1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) Analogues at Monoamine Transporters

    Article • Journal of Medicinal Chemistry, August 2010, American Chemical Society (ACS)

    Jonathan L Katz

  32. ChemInform Abstract: [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4′-fluorophenyl)amine Analogues as Novel Probes for the Dopamine Transporter.

    Article • ChemInform, May 2010, Wiley

    Jonathan L Katz

  33. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats

    Article • Behavioural Pharmacology, May 2010, Wolters Kluwer Health

    Greg Collins, Jonathan L Katz

  34. Citalopram enhances cocaineʼs subjective effects in rats

    Article • Behavioural Pharmacology, December 2009, Wolters Kluwer Health

    Jonathan L Katz

  35. Fluoxetine does not alter the ability of dopamine D1- and D2-like agonists to substitute for cocaine in squirrel monkeys

    Article • Pharmacology Biochemistry and Behavior, April 2009, Elsevier

    Jonathan L Katz

  36. Discovery of Drugs to Treat Cocaine Dependence: Behavioral and Neurochemical Effects of Atypical Dopamine Transport Inhibitors

    Article • January 2009, Elsevier

    Dr Gianluigi Tanda, Jonathan L Katz

  37. Cocaine‐like neurochemical effects of antihistaminic medications

    Article • Journal of Neurochemistry, April 2008, Wiley

    Dr Gianluigi Tanda, Jonathan L Katz

  38. Cocaine-Like Neurochemical Effects of Antihistaminic Medications

    Article • Journal of Neurochemistry, March 2008, Wiley

    Dr Gianluigi Tanda, Jonathan L Katz

  39. Atypical Dopamine Uptake Inhibitors that Provide Clues About Cocaine's Mechanism at the Dopamine Transporter

    Article • January 2008, Springer Science + Business Media

    Jonathan L Katz

  40. Muscarinic preferential M1 receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats

    Article • Pharmacology Biochemistry and Behavior, October 2007, Elsevier

    Dr Gianluigi Tanda, Jonathan L Katz

  41. Design and Synthesis of a Novel Photoaffinity Ligand for the Dopamine and Serotonin Transporters Based on 2β-Carbomethoxy-3β-biphenyltropane

    Article • Journal of Medicinal Chemistry, November 2006, American Chemical Society (ACS)

    Jonathan L Katz

  42. Structure−Activity Relationship Studies on a Novel Series of (S)-2β-Substituted 3α-[Bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane Analogues for in Vivo Investigation

    Article • Journal of Medicinal Chemistry, October 2006, American Chemical Society (ACS)

    Jonathan L Katz

  43. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats

    Article • Behavioural Pharmacology, June 2006, Wolters Kluwer Health

    Jonathan L Katz

  44. Comparative structure–activity relationships of benztropine analogues at the dopamine transporter and histamine H1 receptors

    Article • Bioorganic & Medicinal Chemistry, June 2006, Elsevier

    Jonathan L Katz

  45. N-8-Substituted Benztropinamine Analogues as Selective Dopamine Transporter Ligands.

    Article • ChemInform, March 2006, Wiley

    Jonathan L Katz

  46. Investigation of the potential pharmacokinetic and pharmaco-dynamic drug interaction between AHN 1-055, a potent benztropine analog used for cocaine abuse, and cocaine after dosing in rats using intracerebral microdialysis

    Article • Biopharmaceutics & Drug Disposition, January 2006, Wiley

    Jonathan L Katz

  47. N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands

    Article • Bioorganic & Medicinal Chemistry Letters, December 2005, Elsevier

    Jonathan L Katz

  48. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice

    Article • Pharmacology Biochemistry and Behavior, August 2005, Elsevier

    Jonathan L Katz

  49. Pharmacodynamic Assessment of the Benztropine Analogues AHN-1055 and AHN-2005 Using Intracerebral Microdialysis to Evaluate Brain Dopamine Levels and Pharmacokinetic/Pharmacodynamic Modeling

    Article • Pharmaceutical Research, April 2005, Springer Science + Business Media

    Jonathan L Katz

  50. Synthesis and Biological Evaluation of Meperidine Analogues at Monoamine Transporters

    Article • Journal of Medicinal Chemistry, March 2005, American Chemical Society (ACS)

    Jonathan L Katz

  51. Human Cocaine-Seeking Behavior and its Control by Drug-Associated Stimuli in the Laboratory

    Article • Neuropsychopharmacology, November 2004, Nature

    Jonathan L Katz

  52. Structure−Activity Relationships at Monoamine Transporters for a Series of N-Substituted 3α-(Bis[4-fluorophenyl]methoxy)tropanes:  Comparative Molecular Field Analysis, Synthesis, and Pharmacological Evaluation

    Article • Journal of Medicinal Chemistry, June 2004, American Chemical Society (ACS)

    Jonathan L Katz

  53. The effect of 6-substituted-4′,4″-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor

    Article • Bioorganic & Medicinal Chemistry Letters, June 2004, Elsevier

    Jonathan L Katz

  54. Synthesis and Monoamine Transporter Binding of 2-(Diarylmethoxymethyl)-3β-aryltropane Derivatives

    Article • Journal of Medicinal Chemistry, March 2004, American Chemical Society (ACS)

    Jonathan L Katz

  55. What is represented by vertical shifts in self-administration dose?response curves?

    Article • Psychopharmacology, January 2004, Springer Science + Business Media

    Jonathan L Katz

  56. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D 4 receptor mutant mice

    Article • Psychopharmacology, October 2003, Springer Science + Business Media

    Jonathan L Katz

  57. Locomotor and discriminative-stimulus effects of cocaine in dopamine D 5 receptor knockout mice

    Article • Psychopharmacology, September 2003, Springer Science + Business Media

    Jonathan L Katz

  58. Structure−Activity Relationship Comparison of (S)-2β-Substituted 3α-(Bis[4-fluorophenyl]methoxy)tropanes and (R)-2β-Substituted 3β-(3,4-Dichlorophenyl)tropanes at the Dopamine Transporter

    Article • Journal of Medicinal Chemistry, July 2003, American Chemical Society (ACS)

    Jonathan L Katz

  59. Erratum to The validity of the reinstatement model of craving and relapse to drug use

    Article • Psychopharmacology, June 2003, Springer Science + Business Media

    Jonathan L Katz

  60. Dual Probes for the Dopamine Transporter and σ1Receptors:  Novel Piperazinyl Alkyl-bis(4‘-fluorophenyl)amine Analogues as Potential Cocaine-Abuse Therapeutic Agents

    Article • Journal of Medicinal Chemistry, June 2003, American Chemical Society (ACS)

    Jonathan L Katz

  61. Behavioral effects of rimcazole analogues alone and in combination with cocaine

    Article • European Journal of Pharmacology, May 2003, Elsevier

    Jonathan L Katz

  62. The validity of the reinstatement model of craving and relapse to drug use

    Article • Psychopharmacology, April 2003, Springer Science + Business Media

    Jonathan L Katz

  63. Variability of drug self-administration in rats

    Article • Psychopharmacology, March 2003, Springer Science + Business Media

    Jonathan L Katz

  64. The experimental imperative

    Article • Psychopharmacology, October 2002, Springer Science + Business Media

    Jonathan L Katz

  65. Continuing implications of the early evidence against the drive-reduction hypothesis of the behavioral effects of drugs

    Article • Psychopharmacology, October 2002, Springer Science + Business Media

    Jonathan L Katz

  66. Synthesis and Biological Evaluation of 2-Substituted 3β-Tolyltropane Derivatives at Dopamine, Serotonin, and Norepinephrine Transporters.

    Article • Journal of Medicinal Chemistry, September 2002, American Chemical Society (ACS)

    Jonathan L Katz

  67. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice

    Article • European Journal of Neuroscience, August 2002, Wiley

    Jonathan L Katz

  68. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice

    Article • Psychopharmacology, July 2002, Springer Science + Business Media

    Jonathan L Katz

  69. Intravenous cocaine-induced activity in A/J and C57BL/6J mice: behavioral sensitization and conditioned activity

    Article • Neuropharmacology, June 2002, Elsevier

    Jonathan L Katz

  70. Enantioselective synthesis of S-(+)-2β-carboalkoxy-3α-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter

    Article • Bioorganic & Medicinal Chemistry Letters, May 2002, Elsevier

    Jonathan L Katz

  71. Synthesis and Biological Evaluation of 2-Substituted 3β-Tolyltropane Derivatives at Dopamine, Serotonin, and Norepinephrine Transporters

    Article • Journal of Medicinal Chemistry, March 2002, American Chemical Society (ACS)

    Jonathan L Katz

  72. [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4′-fluorophenyl)amine analogues as novel probes for the dopamine transporter

    Article • Bioorganic & Medicinal Chemistry Letters, December 2001, Elsevier

    Jonathan L Katz

  73. Novel Tropane-Based Irreversible Ligands for the Dopamine Transporter

    Article • Journal of Medicinal Chemistry, December 2001, American Chemical Society (ACS)

    Jonathan L Katz

  74. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents

    Article • Psychopharmacology, September 2001, Springer Science + Business Media

    Jonathan L Katz

  75. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys

    Article • Psychopharmacology, April 2001, Springer Science + Business Media

    Jonathan L Katz

  76. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents

    Article • Psychopharmacology, April 2001, Springer Science + Business Media

    Jonathan L Katz

  77. The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice

    Article • Psychopharmacology, March 2001, Springer Science + Business Media

    Jonathan L Katz

  78. Structure−Activity Relationships at Monoamine Transporters and Muscarinic Receptors forN-Substituted-3α-(3‘-chloro-, 4‘-chloro-, and 4‘,4‘ ‘-dichloro-substituted-diphenyl)methoxytropanes

    Article • Journal of Medicinal Chemistry, February 2001, American Chemical Society (ACS)

    Jonathan L Katz

  79. 2D QSAR Modeling and Preliminary Database Searching for Dopamine Transporter Inhibitors Using Genetic Algorithm Variable Selection of Molconn Z Descriptors

    Article • Journal of Medicinal Chemistry, November 2000, American Chemical Society (ACS)

    Jonathan L Katz

  80. Highly Selective Chiral N-Substituted 3α-[Bis(4‘-fluorophenyl)methoxy]tropane Analogues for the Dopamine Transporter:  Synthesis and Comparative Molecular Field Analysis

    Article • Journal of Medicinal Chemistry, March 2000, American Chemical Society (ACS)

    Jonathan L Katz

  81. Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine

    Article • Bioorganic & Medicinal Chemistry Letters, December 1999, Elsevier

    Jonathan L Katz

  82. Structure−Activity Relationships at the Monoamine Transporters and σ Receptors for a Novel Series of 9-[3-(cis-3,5-Dimethyl-1-piperazinyl)-propyl]carbazole (Rimcazole) Analogues

    Article • Journal of Medicinal Chemistry, October 1999, American Chemical Society (ACS)

    Jonathan L Katz

  83. Synthesis and Dopamine Transporter Affinity of the Four Stereoisomers of (±)-2-(Methoxycarbonyl)-7-methyl-3-phenyl-7-azabicyclo[2.2.1]heptane

    Article • Journal of Medicinal Chemistry, June 1998, American Chemical Society (ACS)

    Jonathan L Katz

  84. Preface

    Article • January 1998, Elsevier

    Jonathan L Katz

  85. Behavioral Pharmacology of Cocaine and the Determinants of Abuse Liability

    Article • January 1998, Elsevier

    Jonathan L Katz

  86. Novel N-Substituted 3α-[Bis(4‘-fluorophenyl)methoxy]tropane Analogues:  Selective Ligands for the Dopamine Transporter

    Article • Journal of Medicinal Chemistry, December 1997, American Chemical Society (ACS)

    Jonathan L Katz

  87. Isothiocyanate Derivatives of 9-[3-(cis-3,5-Dimethyl-1-piperazinyl)propyl]- carbazole (Rimcazole):  Irreversible Ligands for the Dopamine Transporter

    Article • Journal of Medicinal Chemistry, December 1997, American Chemical Society (ACS)

    Jonathan L Katz

  88. Synthesis, Structure, Dopamine Transporter Affinity, and Dopamine Uptake Inhibition of 6-Alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane Derivatives

    Article • Journal of Medicinal Chemistry, December 1997, American Chemical Society (ACS)

    Jonathan L Katz

  89. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats

    Article • Psychopharmacology, November 1997, Springer Science + Business Media

    Jonathan L Katz

  90. N-Methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects

    Article • Brain Research, October 1997, Elsevier

    Jonathan L Katz

  91. The effect of N-methylation on fenfluramine's neurotoxic and pharmacologic actions

    Article • Brain Research, July 1997, Elsevier

    Jonathan L Katz

  92. Relations Between Heterogeneity of Dopamine Transporter Binding and Function and the Behavioral Pharmacology of Cocaine

    Article • Pharmacology Biochemistry and Behavior, July 1997, Elsevier

    Jonathan L Katz

  93. Synthesis, Dopamine Transporter Affinity, Dopamine Uptake Inhibition, and Locomotor Stimulant Activity of 2-Substituted 3β-Phenyltropane Derivatives

    Article • Journal of Medicinal Chemistry, March 1997, American Chemical Society (ACS)

    Jonathan L Katz

  94. 3‘-Chloro-3α-(diphenylmethoxy)tropane But Not 4‘-Chloro-3α- (diphenylmethoxy)tropane Produces a Cocaine-like Behavioral Profile†

    Article • Journal of Medicinal Chemistry, March 1997, American Chemical Society (ACS)

    Jonathan L Katz

  95. The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter

    Article • European Journal of Pharmacology, February 1996, Elsevier

    Jonathan L Katz

  96. Synthesis and Dopamine Transporter Affinity of 2-(Methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane Derivatives

    Article • Journal of Medicinal Chemistry, January 1996, American Chemical Society (ACS)

    Jonathan L Katz

  97. Synthesis and Ligand Binding of η6-(2β-Carbomethoxy-3β-phenyltropane) Transition Metal Complexes

    Article • Journal of Medicinal Chemistry, January 1996, American Chemical Society (ACS)

    Jonathan L Katz

  98. Novel 4'-Substituted and 4',4''-Disubstituted 3.alpha.-(Diphenylmethoxy)tropane Analogs as Potent and Selective Dopamine Uptake Inhibitors

    Article • Journal of Medicinal Chemistry, September 1995, American Chemical Society (ACS)

    Jonathan L Katz

  99. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands

    Article • European Journal of Pharmacology, August 1995, Elsevier

    Jonathan L Katz

  100. Synthesis, Cocaine Receptor Affinity, and Dopamine Uptake Inhibition of Several New 2.beta.-Substituted 3.beta.-Phenyltropanes

    Article • Journal of Medicinal Chemistry, November 1994, American Chemical Society (ACS)

    Jonathan L Katz

  101. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors

    Article • European Journal of Pharmacology, October 1994, Elsevier

    Jonathan L Katz

  102. Novel 3.alpha.-(Diphenylmethoxy)tropane Analogs: Potent Dopamine Uptake Inhibitors without Cocaine-like Behavioral Profiles

    Article • Journal of Medicinal Chemistry, July 1994, American Chemical Society (ACS)

    Jonathan L Katz

  103. Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat

    Article • Pharmacology Biochemistry and Behavior, March 1994, Elsevier

    Jonathan L Katz

  104. 7-OH-DPAT antagonizes dopamine D2 receptor-inhibited adenylyl cyclase activity

    Article • Life Sciences, January 1994, Elsevier

    Jonathan L Katz

  105. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393

    Article • Psychopharmacology, January 1994, Springer Science + Business Media

    Jonathan L Katz

  106. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey

    Article • Psychopharmacology, November 1993, Springer Science + Business Media

    Jonathan L Katz

  107. Cocaine and several σ receptor ligands inhibit dopamine uptake in rat caudate-putamen

    Article • European Journal of Pharmacology, October 1993, Elsevier

    Jonathan L Katz

  108. Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat

    Article • European Journal of Pharmacology Molecular Pharmacology, June 1993, Elsevier

    Jonathan L Katz

  109. Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat

    Article • Psychopharmacology, December 1992, Springer Science + Business Media

    Jonathan L Katz

  110. Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys

    Article • Psychopharmacology, October 1992, Springer Science + Business Media

    Jonathan L Katz

  111. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA)

    Article • Brain Research, September 1992, Elsevier

    Jonathan L Katz

  112. Reinforcing effects of enantiomers of N,N-dimethylamphetamine in squirrel monkeys

    Article • Psychopharmacology, June 1992, Springer Science + Business Media

    Jonathan L Katz

  113. Effects of cocaine and its quaternary derivative cocaine methiodide on cardiovascular function in squirrel monkeys

    Article • European Journal of Pharmacology, March 1992, Elsevier

    Jonathan L Katz

  114. Carbamazepine produces nonspecific effects on cocaine self-administration in rats

    Article • Life Sciences, January 1992, Elsevier

    Jonathan L Katz

  115. Comparative behavioral pharmacology and toxicology of cocaine and its ethhanol-derived metabolite, cocaine ethyl-ester (cocaethylene)

    Article • Life Sciences, January 1992, Elsevier

    Jonathan L Katz

  116. Selective σ ligands block stimulant effects of cocaine

    Article • European Journal of Pharmacology, August 1991, Elsevier

    Jonathan L Katz

  117. The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat

    Article • Pharmacology Biochemistry and Behavior, July 1991, Elsevier

    Jonathan L Katz

  118. Modern Methods in Pharmacology Vol. 6. Testing and Evaluation of Drugs of Abuse

    Article • Behavioural Pharmacology, June 1991, Wolters Kluwer Health

    Jonathan L Katz

  119. Scratching induced by dopamine D-2 agonists in squirrel monkeys

    Article • Pharmacology Biochemistry and Behavior, May 1991, Elsevier

    Jonathan L Katz

  120. Methohexital and cocaine self-administration under fixed-ratio and second-order schedules

    Article • Pharmacology Biochemistry and Behavior, February 1991, Elsevier

    Jonathan L Katz

  121. Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey

    Article • Psychopharmacology, January 1991, Springer Science + Business Media

    Jonathan L Katz

  122. Analysis of behavioral effects of drugs

    Article • Drug Development Research, January 1990, Wiley

    Jonathan L Katz

  123. Some behavioral effects of repeatedd-amphetamine administrations

    Article • Drug Development Research, January 1990, Wiley

    Jonathan L Katz

  124. Effects of a selective κ-opioid agonist, U-50,488H, on morphine dependence in rats

    Article • European Journal of Pharmacology, October 1989, Elsevier

    Jonathan L Katz

  125. Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice

    Article • Psychopharmacology, August 1989, Springer Science + Business Media

    Jonathan L Katz

  126. Can we scale reinforcing efficacy of drugs and does it tell us anything about abuse liability?

    Article • Pharmacology Biochemistry and Behavior, April 1989, Elsevier

    Jonathan L Katz

  127. Two types of bias in psychophysical detection and recognition procedures: nonparametric indices and effects of drugs

    Article • Psychopharmacology, February 1989, Springer Science + Business Media

    Jonathan L Katz

  128. Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol

    Article • Life Sciences, January 1989, Elsevier

    Jonathan L Katz

  129. Progress in understanding the relationship between the adenosine receptor system and actions of methylxanthines

    Article • Pharmacology Biochemistry and Behavior, February 1988, Elsevier

    Jonathan L Katz

  130. Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey

    Article • Pharmacology Biochemistry and Behavior, February 1988, Elsevier

    Jonathan L Katz

  131. Second-Order Schedules of Drug Injection

    Article • January 1987, Springer Science + Business Media

    Jonathan L Katz

  132. Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine

    Article • Psychopharmacology, November 1985, Springer Science + Business Media

    Jonathan L Katz

  133. Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonines (C-homobenzomorphans).

    Article • The Japanese Journal of Pharmacology, January 1985, Japanese Pharmacological Society

    Jonathan L Katz

  134. The opiate quasiwithdrawal syndrome in rhesus monkeys: Comparison of naloxone-precipitated withdrawal to effects of cholinergic agents

    Article • Psychopharmacology, September 1984, Springer Science + Business Media

    Jonathan L Katz

  135. Effects of clonidine and some ?-adrenergic antagonists alone and in combination on schedule-controlled behavior in pigeons and mice

    Article • Psychopharmacology, April 1984, Springer Science + Business Media

    Jonathan L Katz

  136. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists

    Article • Life Sciences, June 1983, Elsevier

    Jonathan L Katz

  137. Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys

    Article • Life Sciences, January 1983, Elsevier

    Jonathan L Katz

  138. Compounds of novel structure having kappa-agonist behavioral effects in Rhesus monkeys

    Article • Life Sciences, November 1982, Elsevier

    Jonathan L Katz

  139. Behavioral Effects of Levonantradol and Nantradol in the Rhesus Monkey

    Article • The Journal of Clinical Pharmacology, August 1981, Wiley

    Jonathan L Katz

  140. Drug Effects on Behaviors Maintained by Different Events

    Article • January 1981, Elsevier

    Jonathan L Katz

  141. Conjunctive schedules of reinforcement IV: Effects on the pattern of responding of changes in requirement at reinforcement

    Article • Animal Learning & Behavior, December 1979, Springer Science + Business Media

    Jonathan L Katz

  142. Mathematics relevant to rate-dependent drug effects

    Article • Neuroscience & Biobehavioral Reviews, March 1979, Elsevier

    Jonathan L Katz

  143. Effects of d-amphetamine and ethanol alone and in combination on schedule-controlled responding of pigeons

    Article • Psychopharmacology, January 1979, Springer Science + Business Media

    Jonathan L Katz

  144. Ethanol, pentobarbital, and chlordiazepoxide effects in squirrel monkeys responding under fixed-ratio food presentation and stimulus-shock termination schedules

    Article • Psychopharmacology, January 1978, Springer Science + Business Media

    Jonathan L Katz

  145. Effects of d-amphetamine and ethanol on responding of squirrel monkeys maintained under fixed-ratio schedules of food presentation and stimulus-shock termination

    Article • Pharmacology Biochemistry and Behavior, January 1978, Elsevier

    Jonathan L Katz

  146. Preclinical Assessment of Cocaine Toxicity: Mechanisms and Pharmacotherapy

    Article • American Psychological Association (APA)

    Jonathan L Katz

  147. Behavioral pharmacology of licit drugs in experimental animals.

    Article • American Psychological Association (APA)

    Jonathan L Katz

  148. Intravenous cocaine self-administration by human volunteers: Second-order schedules of reinforcement.

    Article • American Psychological Association (APA)

    Jonathan L Katz

  149. The use of second-order schedules to study the influence of environmental stimuli on drug-seeking behavior.

    Article • American Psychological Association (APA)

    Jonathan L Katz

  150. The Use of Second-Order Schedules To Study the Influence of Environmental Stimuli on Drug- Seeking Behavior

    Article • American Psychological Association (APA)

    Jonathan L Katz